This result is in support of the proposed mechanism of action of sorafenib to trigger apoptosis in hepatoma cells [66], a process that is also activated by EDEM3 depletion (our results, Fig. 4). The gene discussed is EDEM3; the disease is hepatocellular carcinoma.